|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cost of sales: | |||||
| Operating costs | |||||
| Crude oil stock fluctuation | |||||
| Royalties and others | |||||
| Depreciation, depletion and amortization | |||||
| Royalties | |||||
| Other non-cash costs related to the transfer of conventional assets | |||||
| Gross profit | |||||
| Selling expenses | |||||
| General and administrative expenses | |||||
| Exploration expenses | |||||
| Other operating income | |||||
| Other operating expenses | |||||
| Impairment of long- lived assets | |||||
| Operating profit | |||||
| Income (loss) from investments in associates | |||||
| Interest income | |||||
| Interest expense | |||||
| Other financial income (expense) | |||||
| Financial income (expense), net | |||||
| Current income tax (expense) | |||||
| Deferred income tax (expense) benefit | |||||
| Income tax (expense) | |||||
| Profit for the year, net | |||||
| Other comprehensive income | |||||
| Other comprehensive income that shall not be reclassified to profit (loss) in subsequent years | |||||
| - Profit (loss) from actuarial remeasurement related to employee benefits | |||||
| - Deferred income tax (expense) benefit | |||||
| Other comprehensive income for the year | |||||
| Total comprehensive profit for the year | |||||
| Earnings per share | |||||
| Basic (in US Dollars per share) | |||||
| Diluted (in US Dollars per share) |
Loading...